Tesla
TSLA
Apple
AAPL
Meta Platforms
META
4
Microsoft
MSFT
5
Petroleo Brasileiro SA Petrobras
PBR
US Stock MarketDetailed Quotes
MURA Mural Oncology
- 3.850
- -0.020-0.52%
Close Mar 21 16:00 ET
- 3.850
- 0.0000.00%
Post 20:01 ET
66.33MMarket Cap-0.51P/E (TTM)
3.986High3.800Low43.17KVolume3.810Open3.870Pre Close168.02KTurnover0.34%Turnover RatioLossP/E (Static)17.23MShares5.12052wk High0.47P/B48.87MFloat Cap2.87052wk Low--Dividend TTM12.69MShs Float57.200Historical High--Div YieldTTM4.82%Amplitude2.870Historical Low3.891Avg Price1Lot Size
Mural Oncology Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 33.82%-128.55M | 25.64%-31.77M | 40.41%-30.08M | 35.21%-29.36M | 33.01%-37.34M | -15.22%-194.25M | -12.77%-42.73M | -35.31%-50.47M | -45.32M | -55.74M |
| Net income from continuing operations | 38.05%-128.51M | 42.43%-34.27M | 38.07%-31.76M | 37.08%-31.56M | 33.46%-30.92M | -9.29%-207.45M | -22.55%-59.54M | -1.26%-51.28M | ---50.16M | ---46.47M |
| Operating gains losses | --96K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 36.81%3.51M | 41.60%868K | 15.40%899K | 39.38%899K | 59.62%846K | 66.69%2.57M | 23.34%613K | 109.41%779K | --645K | --530K |
| Change In working capital | 55.14%-6.05M | -38.82%591K | 111.65%344K | 133.99%2.49M | 24.59%-9.47M | -273.95%-13.48M | -86.20%966K | -131.10%-2.95M | --1.06M | ---12.55M |
| -Change in receivables | --5.5M | --1.34M | ---388K | --890K | --3.65M | --0 | --0 | --0 | --0 | --0 |
| -Change in prepaid assets | -365.28%-7.53M | -172.44%-1.53M | 1,297.56%573K | -341.37%-1.48M | -596.97%-5.09M | 460.48%2.84M | 661.01%2.11M | -90.42%41K | ---336K | --1.02M |
| -Change in payables and accrued expense | 86.70%-2.43M | 139.39%1.16M | 105.57%151K | 100.86%4.18M | 45.95%-7.93M | -317.50%-18.25M | -156.20%-2.96M | -128.60%-2.71M | --2.08M | ---14.66M |
| -Change in other current assets | -36.80%5.12M | -71.62%994K | 15.56%1.4M | 45.25%1.3M | -42.87%1.42M | 32.35%8.1M | 19.07%3.5M | 11.16%1.22M | --895K | --2.48M |
| -Change in other current liabilities | -8.77%-6.71M | 18.22%-1.38M | 6.87%-1.4M | -52.28%-2.41M | -9.02%-1.52M | -3.25%-6.17M | -14.58%-1.69M | 0.27%-1.5M | ---1.58M | ---1.4M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 33.82%-128.55M | 25.64%-31.77M | 40.41%-30.08M | 35.21%-29.36M | 33.01%-37.34M | -15.22%-194.25M | -12.77%-42.73M | -35.31%-50.47M | ---45.32M | ---55.74M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -633.78%-25.33M | 3,174.19%36.21M | 1,756.35%19.31M | 6,252.54%43.68M | -31,191.46%-124.54M | 37.36%-3.45M | -723.78%-1.18M | 56.75%-1.17M | -710K | -398K |
| Net PPE purchase and sale | 99.28%-25K | 103.74%44K | 98.80%-14K | --0 | 86.18%-55K | 37.36%-3.45M | -723.78%-1.18M | 56.75%-1.17M | ---710K | ---398K |
| Net investment purchase and sale | ---25.31M | --36.17M | --19.33M | --43.68M | ---124.49M | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -633.78%-25.33M | 3,174.19%36.21M | 1,756.35%19.31M | 6,252.54%43.68M | -31,191.46%-124.54M | 37.36%-3.45M | -723.78%-1.18M | 56.75%-1.17M | ---710K | ---398K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.96%196K | 0 | -99.62%196K | 0 | 0 | 169.28%468.81M | 728.35%315.01M | 29.11%51.64M | 46.03M | 56.14M |
| Net common stock issuance | --196K | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | 169.28%468.81M | 728.35%315.01M | 29.11%51.64M | --46.03M | --56.14M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.96%196K | --0 | -99.62%196K | --0 | --0 | 169.28%468.81M | 728.35%315.01M | 29.11%51.64M | --46.03M | --56.14M |
| Net cash flow | ||||||||||
| Beginning cash position | --271.11M | --112.99M | --123.56M | --109.23M | --271.11M | --0 | --0 | --0 | --0 | --0 |
| Current changes in cash | -156.69%-153.68M | --4.44M | ---10.57M | --14.32M | ---161.88M | --271.11M | ---- | ---- | ---- | ---- |
| End cash Position | -56.69%117.43M | -56.69%117.43M | --112.99M | --123.56M | --109.23M | --271.11M | --271.11M | --0 | --0 | --0 |
| Free cash flow | 34.93%-128.64M | 27.58%-31.79M | 41.72%-30.09M | 36.21%-29.36M | 33.39%-37.39M | -13.56%-197.7M | -15.45%-43.9M | -29.11%-51.64M | ---46.03M | ---56.14M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025